Drug Information Association

The Drug Information Association (DIA) is a 501(c)(3) non-profit association registered in Pennsylvania and headquartered in Washington DC, USA.

The DIA was founded in 1964 in Maryland, United States, by a group of thirty pharmaceutical professionals, medical writers, industry professionals and academicians. The goal of DIA was to facilitate communications and foster cooperative efforts among professionals working in health care industries primarily engaged in drug development, medical communications and health information. The founding of DIA was closely tied to the passing of the Kefauver Harris Amendment after the devastation of thalidomide, a sedative used to treat morning sickness in pregnant women that was causing birth defects. Thomas W. Teal, a pharmaceutical executive and DIA’s founder, strongly supported a method of providing accurate up-to -date pharmaceutical information, thus the founding of DIA.